Cibc World Markets Corp Krystal Biotech, Inc. Transaction History
Cibc World Markets Corp
- $16.6 Billion
- Q4 2024
A detailed history of Cibc World Markets Corp transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 2,321 shares of KRYS stock, worth $361,495. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,321Holding current value
$361,495% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KRYS
# of Institutions
308Shares Held
24.5MCall Options Held
506KPut Options Held
383K-
Black Rock Inc. New York, NY3.95MShares$615 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.88MShares$448 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.63MShares$409 Million6.0% of portfolio
-
State Street Corp Boston, MA1.28MShares$199 Million0.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$154 Million9.67% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...